150 related articles for article (PubMed ID: 36876759)
41. The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Marchevsky AM; LeStang N; Hiroshima K; Pelosi G; Attanoos R; Churg A; Chirieac L; Dacic S; Husain A; Khoor A; Klebe S; Lantuejoul S; Roggli V; Vignaud JM; Weynard B; Sauter J; Henderson D; Nabeshima K; Galateau-Salle F
Hum Pathol; 2017 Sep; 67():160-168. PubMed ID: 28782639
[TBL] [Abstract][Full Text] [Related]
42. Mesothelial and related neoplasms in children and adolescents: a clinicopathologic and immunohistochemical analysis of eight cases.
Coffin CM; Dehner LP
Pediatr Pathol; 1992; 12(3):333-47. PubMed ID: 1384016
[TBL] [Abstract][Full Text] [Related]
43. Well-Differentiated Papillary Mesothelial Tumor: An Unusual Radiologic Presentation: A Case Report.
Abdelghafar M; Anand K; Paiva-Correia A; Smith EP; Salle FG; Joshi V
J Chest Surg; 2023 May; 56(3):220-223. PubMed ID: 37131285
[TBL] [Abstract][Full Text] [Related]
44. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases.
Galateau-Sallé F; Vignaud JM; Burke L; Gibbs A; Brambilla E; Attanoos R; Goldberg M; Launoy G;
Am J Surg Pathol; 2004 Apr; 28(4):534-40. PubMed ID: 15087673
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.
Lee YK; Jun HJ; Nahm JH; Lim TS; Park JS; Ahn JB; Rha SY; Chung HC; Oh HE; Song JS; Yang WI; Kim HS
Jpn J Clin Oncol; 2013 Oct; 43(10):996-1003. PubMed ID: 23964112
[TBL] [Abstract][Full Text] [Related]
46. Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients.
Liu S; Staats P; Lee M; Alexander HR; Burke AP
Pathology; 2014 Dec; 46(7):604-9. PubMed ID: 25393250
[TBL] [Abstract][Full Text] [Related]
47. The value of BRCA-1-associated protein 1 expression and cyclin-dependent kinase inhibitor 2A deletion to distinguish peritoneal malignant mesothelioma from peritoneal location of carcinoma in effusion cytology specimens.
Althakfi W; Gazzo S; Blanchet M; Isaac S; Piaton E; Villeneuve L; Glehen O; Gilly FN; Brevet M
Cytopathology; 2020 Jan; 31(1):5-11. PubMed ID: 31713897
[TBL] [Abstract][Full Text] [Related]
48. Peritoneal mesothelioma: the site of origin matters.
Kindler HL
Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495
[TBL] [Abstract][Full Text] [Related]
49. Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology.
Chevrier M; Monaco SE; Jerome JA; Galateau-Salle F; Churg A; Dacic S
Cancer Cytopathol; 2020 Dec; 128(12):939-947. PubMed ID: 32678499
[TBL] [Abstract][Full Text] [Related]
50. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
Singhi AD; Krasinskas AM; Choudry HA; Bartlett DL; Pingpank JF; Zeh HJ; Luvison A; Fuhrer K; Bahary N; Seethala RR; Dacic S
Mod Pathol; 2016 Jan; 29(1):14-24. PubMed ID: 26493618
[TBL] [Abstract][Full Text] [Related]
51. Malignant peritoneal mesothelioma in patients with endometriosis.
Butnor KJ; Rueckert J; Pavlisko EN; Sporn TA; Roggli VL
J Clin Pathol; 2018 Nov; 71(11):971-974. PubMed ID: 29794065
[TBL] [Abstract][Full Text] [Related]
52. Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology.
Nasit JG; Dhruva G
Am J Clin Pathol; 2014 Aug; 142(2):233-42. PubMed ID: 25015866
[TBL] [Abstract][Full Text] [Related]
53. Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.
Pillappa R; Maleszewski JJ; Sukov WR; Bedroske PP; Greipp PT; Boland JM; Yi ES; Peikert T; Aubry MC; Roden AC
Am J Surg Pathol; 2018 Feb; 42(2):256-263. PubMed ID: 29076876
[TBL] [Abstract][Full Text] [Related]
54. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma.
Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C
Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380
[TBL] [Abstract][Full Text] [Related]
55. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42.
Stevers M; Rabban JT; Garg K; Van Ziffle J; Onodera C; Grenert JP; Yeh I; Bastian BC; Zaloudek C; Solomon DA
Mod Pathol; 2019 Jan; 32(1):88-99. PubMed ID: 30171198
[TBL] [Abstract][Full Text] [Related]
56. Localized malignant mesothelioma.
Allen TC; Cagle PT; Churg AM; Colby TV; Gibbs AR; Hammar SP; Corson JM; Grimes MM; Ordonez NG; Roggli V; Travis WD; Wick MR
Am J Surg Pathol; 2005 Jul; 29(7):866-73. PubMed ID: 15958850
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous bilateral spontaneous pneumothorax in a patient with peritoneal and pleural papillary mesothelioma.
Höllinger P; Gaeng D
Respiration; 1997; 64(3):233-5. PubMed ID: 9154677
[TBL] [Abstract][Full Text] [Related]
58. Peritoneal malignant mesothelioma: Slippery like an eel to diagnose on cytology-case series of 3 cases.
Gupta N; Soni A; Mahajan R; Selhi P; Tyagi R; Garg B; Kaur H
J Am Soc Cytopathol; 2022; 11(1):40-45. PubMed ID: 34602383
[TBL] [Abstract][Full Text] [Related]
59. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
[TBL] [Abstract][Full Text] [Related]
60. Pathohistological diagnosis and differential diagnosis.
Tischoff I; Neid M; Neumann V; Tannapfel A
Recent Results Cancer Res; 2011; 189():57-78. PubMed ID: 21479896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]